The duodenal-jejunal bypass liner (EndoBarrier®) for the treatment of type 2 diabetes mellitus in obese patients – efficacy and factors predicting optimal effects

2016 ◽  
Vol 70 (6) ◽  
pp. 491-499
Author(s):  
Marek Beneš ◽  
Tomáš Hucl ◽  
Pavel Drastich ◽  
Radan Keil ◽  
Zuzana Vlasáková ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Obese Patients ◽  
Jejunal Bypass

Treatment of type 2 diabetes mellitus with the endoscopic duodenal-jejunal bypass liner (EndoBarrier®)

2014 ◽  
Vol 9 (S 01) ◽  
Author(s):  
K Laubner ◽  
L Potasso ◽  
N Perakakis ◽  
H Schwacha ◽  
J Seufert
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Jejunal Bypass

Real world data of Type 2 Diabetes Mellitus (T2DM) obese patients using another GLP1 receptor agonist (GLP1–RA) and switching to Semaglutide in Spain

2020 ◽  
Author(s):  
Jersy Cardenas ◽  
Gomez Nancy Sanchez ◽  
Sierra Poyatos Roberto Miguel ◽  
Luca Bogdana Luiza ◽  
Mostoles Naiara Modroño ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Real World ◽  
Receptor Agonist ◽  
Obese Patients ◽  
Real World Data ◽  
World Data
Sign in / Sign up

Export Citation Format

Share Document